Shopping Cart
Remove All
Your shopping cart is currently empty
Gypenoside LXXV, derived from Gynostemma pentaphyllum, is a deglycosylated form of ginsenoside Rb1. This compound effectively decreases cancer cell viability and exhibits potent anti-cancer properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $782 | - | In Stock |
| Description | Gypenoside LXXV, derived from Gynostemma pentaphyllum, is a deglycosylated form of ginsenoside Rb1. This compound effectively decreases cancer cell viability and exhibits potent anti-cancer properties. |
| In vitro | Gypenoside LXXV administered at concentrations ranging from 1.0 to 100 μM for 48 hours effectively decreases cell proliferation in a dose-dependent manner across three cancer cell lines: HeLa (cervical cancer), B16 (melanoma), and MDA-MB231 (human breast cancer). A concentration of 50 μM was notably effective, significantly reducing proliferation and nearly inhibiting all targeted cancer cells[1]. |
| Molecular Weight | 785.025 |
| Formula | C42H72O13 |
| Cas No. | 110261-98-8 |
| Color | White |
| Appearance | Solid |
| Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.